Hansa Biopharma AB
F:24H
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hansa Biopharma AB
F:24H
|
SE |
|
L
|
LG Chem Ltd
KRX:051915
|
KR |
|
T
|
Tapestry Inc
F:COY
|
US |
|
T
|
Treasury Wine Estates Ltd
OTC:TSRYY
|
AU |
|
G
|
Gruppo MutuiOnline SpA
F:MNL
|
IT |
|
C
|
Carlisle Companies Inc
DUS:CLE
|
US |
|
M
|
ME Therapeutics Holdings Inc
CNSX:METX
|
CA |
|
W
|
WD-40 Co
F:WD1
|
US |
|
F
|
Fluor Corp
BMV:FLR
|
US |
|
Master Drilling Group Ltd
F:I49
|
ZA |
|
P
|
P2Earn Inc
CNSX:PXE
|
CA |
|
Klaveness Combination Carriers ASA
F:36K
|
NO |
|
888 Holdings PLC
LSE:EVOK
|
GI |
|
R
|
Rotork PLC
OTC:RTOXF
|
UK |
|
C
|
China Merchants Port Holdings Co Ltd
SWB:CPM
|
HK |
|
H.U. Group Holdings Inc
TSE:4544
|
JP |
|
Daito Trust Construction Co Ltd
F:4D7
|
JP |
|
M
|
Mediobanca Banca di Credito Finanziario SpA
LSE:0HBF
|
IT |
|
A
|
Adidas AG
F:ADS
|
DE |
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
AU |
|
H
|
Heidelberg Pharma AG
XHAM:HPHA
|
DE |
|
H
|
Henderson Land Development Co Ltd
SWB:HLD
|
HK |
|
S
|
Severn Trent PLC
F:SVT1
|
UK |
|
A
|
Accelerate Diagnostics Inc
XBER:1A8
|
US |
Bankruptcy Probability
Hansa Biopharma AB's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Hansa Biopharma AB Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SE |
|
Hansa Biopharma AB
STO:HNSA
|
3.3B SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
449.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
200.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
123.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
71.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Hansa Biopharma AB's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Hansa Biopharma AB has total debt of 1.1B SEK. This includes both short-term (0 SEK) and long-term (1.1B SEK) debt.
You can find a full breakdown on its Balance Sheet.
